1
TITLE: Uveal melanoma: physiopathology and new in situ-specific therapies  Full Text
AUTHORS: Souto, EB ; Zielinska, A; Luis, M; Carbone, C; Martins Gomes, C; Souto, SB; Silva, AM;
PUBLISHED: 2019, SOURCE: CANCER CHEMOTHERAPY AND PHARMACOLOGY, VOLUME: 84, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef: 26
IN MY: ORCID
2
TITLE: Therapeutic Interventions for Countering Leishmaniasis and Chagas's Disease: From Traditional Sources to Nanotechnological Systems
AUTHORS: Souto, EB ; Dias-Ferreira, João ; Craveiro, SA; Severino, P; Sanchez Lopez, E; Garcia, ML; Silva, AM; Souto, SB; Mahant, S;
PUBLISHED: 2019, SOURCE: PATHOGENS, VOLUME: 8, ISSUE: 3
INDEXED IN: Scopus WOS CrossRef: 23
IN MY: ORCID
3
TITLE: Sirtuins and SIRT6 in Carcinogenesis and in Diet  Full Text
AUTHORS: Teixeira, MD; Sanchez Lopez, E; Espina, M; Garcia, ML; Durazzo, A; Lucarini, M; Novellino, E; Souto, SB; Santini, A; Souto, EB ;
PUBLISHED: 2019, SOURCE: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, VOLUME: 20, ISSUE: 19
INDEXED IN: Scopus WOS CrossRef: 16
IN MY: ORCID
4
TITLE: Sugar-Lowering Drugs for Type 2 Diabetes Mellitus and Metabolic Syndrome-Strategies for In Vivo Administration: Part-II
AUTHORS: Vieira, R; Souto, SB; Sanchez Lopez, E; Machado, AL; Severino, P; Jose, S; Santini, A; Silva, AM; Fortuna, A; Garcia, ML; Souto, EB ;
PUBLISHED: 2019, SOURCE: JOURNAL OF CLINICAL MEDICINE, VOLUME: 8, ISSUE: 9
INDEXED IN: WOS CrossRef: 36
5
TITLE: Linseed Essential Oil - Source of Lipids as Active Ingredients for Pharmaceuticals and Nutraceuticals
AUTHORS: Campos, JR; Severino, P; Ferreira, CS; Zielinska, A; Santini, A; Souto, SB; Souto, EB ;
PUBLISHED: 2019, SOURCE: CURRENT MEDICINAL CHEMISTRY, VOLUME: 26, ISSUE: 24
INDEXED IN: Scopus WOS CrossRef: 34
IN MY: ORCID
6
TITLE: Myasthenia gravis: State of the art and new therapeutic strategies  Full Text
AUTHORS: Souto, EB ; Lima, B; Campos, JR; Martins Gomes, C; Souto, SB; Silva, AM;
PUBLISHED: 2019, SOURCE: JOURNAL OF NEUROIMMUNOLOGY, VOLUME: 337
INDEXED IN: Scopus WOS CrossRef: 9
IN MY: ORCID
7
TITLE: Sugar-Lowering Drugs for Type 2 Diabetes Mellitus and Metabolic Syndrome-Review of Classical and New Compounds: Part-I  Full Text
AUTHORS: Vieira, R; Souto, SB; Sanchez Lopez, E; Machado, AL; Severino, P; Jose, S; Santini, A; Fortuna, A; Garcia, ML; Silva, AM; Souto, EB ;
PUBLISHED: 2019, SOURCE: PHARMACEUTICALS, VOLUME: 12, ISSUE: 4
INDEXED IN: Scopus WOS CrossRef: 52
IN MY: ORCID
8
TITLE: Trends in Atopic Dermatitis-From Standard Pharmacotherapy to Novel Drug Delivery Systems  Full Text
AUTHORS: Eliana B Souto ; Dias-Ferreira, João ; Jessica Oliveira; Elena Sanchez Lopez; Ana Lopez Machado; Marta Espina; Maria L Garcia; Selma B Souto; Carlos Martins Gomes; Amelia M Silva;
PUBLISHED: 2019, SOURCE: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, VOLUME: 20, ISSUE: 22
INDEXED IN: Scopus WOS CrossRef: 45
IN MY: ORCID
9
TITLE: Cationic Surfactants: Self-Assembly, Structure-Activity Correlation and Their Biological Applications  Full Text
AUTHORS: Zakharova, LY; Pashirova, TN; Doktorovova, S; Fernandes, AR; Sanchez Lopez, E; Silva, AM; Souto, SB; Souto, EB ;
PUBLISHED: 2019, SOURCE: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, VOLUME: 20, ISSUE: 22
INDEXED IN: Scopus WOS CrossRef: 46
IN MY: ORCID
10
TITLE: Nanoparticle Delivery Systems in the Treatment of Diabetes Complications  Full Text
AUTHORS: Souto, EB ; Souto, SB; Campos, JR; Severino, P; Pashirova, TN; Zakharova, LY; Silva, AM; Durazzo, A; Lucarini, M; Izzo, AA; Santini, A;
PUBLISHED: 2019, SOURCE: MOLECULES, VOLUME: 24, ISSUE: 23
INDEXED IN: Scopus WOS CrossRef: 61
IN MY: ORCID
Page 1 of 3. Total results: 28.